Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'.
Siddharth JainArghya ChattopadhyayPublished in: Annals of the rheumatic diseases (2021)